SCHEMBL2908083

SCHEMBL2908083

Nc1ccc(C=CC(=O)O)cc1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.59
KDM4E B2RXH2 6/20 0.58
HSD17B10 Q99714 3/20 0.58
CA12 O43570 3/20 0.58
CA1 P00915 3/20 0.58
CA2 P00918 3/20 0.58
CA3 P07451 3/20 0.58
CA4 P22748 3/20 0.58
CA6 P23280 3/20 0.58
CA5A P35218 3/20 0.58
CA7 P43166 3/20 0.58
CA9 Q16790 3/20 0.58
CA14 Q9ULX7 3/20 0.58
CA5B Q9Y2D0 3/20 0.58
MAPK1 P28482 3/20 0.58
AKR1B10 O60218 3/20 0.58
AKR1B1 P15121 3/20 0.58
DPP4 P27487 2/20 0.58
HDAC3 O15379 2/20 0.58
HDAC4 P56524 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2908080 1.00 NPSR1 (0.59) NPSR1KDM4EHSD17B10CA12CA1
SCHEMBL9484682 0.85 KDM4E (0.70) NPSR1KDM4EHSD17B10CA12CA1
SCHEMBL9484291 0.85 KDM4E (0.70) NPSR1KDM4EHSD17B10CA12CA1
SCHEMBL13811028 0.85 NPSR1 (0.56) NPSR1KDM4EHSD17B10CA12CA1
SCHEMBL9484287 0.85 KDM4E (0.70) NPSR1KDM4EHSD17B10CA12CA1
SCHEMBL9484685 0.85 KDM4E (0.70) NPSR1KDM4EHSD17B10CA12CA1
SCHEMBL15527953 0.85 NPSR1 (0.56) NPSR1KDM4EHSD17B10CA12CA1
SCHEMBL16345020 0.83 NPSR1 (0.54) NPSR1KDM4EHSD17B10CA12CA1
SCHEMBL20472039 0.83 AKR1C3 (0.62) NPSR1KDM4EHSD17B10CA12CA1
SCHEMBL8310794 0.83 NPSR1 (0.54) NPSR1KDM4EHSD17B10CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795250-B2 Indole derivatives as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-09-14 US disclosed
EP-1758857-B1 INDOLE DERIVATIVES AS ANTIVIRAL AGENTS ANGELETTI P IST RICHERCHE BIO (IT) 2010-08-18 EP disclosed
US-20080261944-A1 Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2008-10-23 US disclosed
EP-1758857-A1 INDOLE DERIVATIVES AS ANTIVIRAL AGENTS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2007-03-07 EP disclosed
WO-2006029912-A1 INDOLE DERIVATIVES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261944-A1 Indole Derivatives as Antiviral Agents IDO1, IDO2, IRF3 NPSR1 163/4885KDM4E 656/4885HSD17B10 1687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.